UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Journal of hepatology, 2019-05, Vol.70 (5), p.1019-1023

2019

Link zum Volltext

Verfügbarkeit prüfen

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

World journal of gastroenterology : WJG, 2014-08, Vol.20 (31), p.10984-10993

2014

Link zum Volltext

Verfügbarkeit prüfen

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Hepatology communications, 2022-09, Vol.6 (9), p.2488-2495

2022

Link zum Volltext

Verfügbarkeit prüfen

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

World journal of gastroenterology : WJG, 2012-03, Vol.18 (12), p.1339-1347

Claus Niederau Dietrich Huppe EImar Zehnter Bernd Moiler, Renate Heyne Stefan Christensen Rainer Waft Arno Theilmeier Ulrich Alshuth Stefan Mauss

2012

Link zum Volltext

Verfügbarkeit prüfen

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

Hepatology (Baltimore, Md.), 2014-01, Vol.59 (1), p.46-48

2014

Link zum Volltext

Verfügbarkeit prüfen

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

Liver international, 2017-08, Vol.37 (8), p.1253-1254

2017

Link zum Volltext

Verfügbarkeit prüfen

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Journal of hepatology, 2017-11, Vol.67 (5), p.918-924

2017

Link zum Volltext

Verfügbarkeit prüfen

Prescription of new HCV-drugs - what has to be considered judicially

Zeitschrift fur Gastroenterologie, 2015-01, Vol.53 (1), p.43

Mauss, Stefan

2015

Link zum Volltext

Verfügbarkeit prüfen

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

Journal of hepatology, 2018-04, Vol.68 (4), p.663-671

2018

Link zum Volltext

Verfügbarkeit prüfen

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Journal of viral hepatitis, 2021-10, Vol.28 (10), p.1474-1483

2021

Link zum Volltext

Verfügbarkeit prüfen

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Liver international, 2021-05, Vol.41 (5), p.949-955

2021

Link zum Volltext

Verfügbarkeit prüfen

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Liver international, 2020-03, Vol.40 (3), p.539-548

2020

Link zum Volltext

Verfügbarkeit prüfen

Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection

Hepatology (Baltimore, Md.), 2004-12, Vol.40 (6), p.1421-1425

2004

Link zum Volltext

Verfügbarkeit prüfen

Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)

Zeitschrift fur Gastroenterologie, 2023-05, Vol.61 (5), p.489

2023

Link zum Volltext

Verfügbarkeit prüfen

Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial

Hepatology (Baltimore, Md.), 2013-06, Vol.57 (6), p.2143-2154

2013

Link zum Volltext

Verfügbarkeit prüfen

Reply to: “Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030”

Journal of hepatology, 2017-08, Vol.67 (2), p.420-422

2017

Link zum Volltext

Verfügbarkeit prüfen

Treatment of viral hepatitis in HIV–coinfected patients–adverse events and their management

Journal of hepatology, 2006, Vol.44 (1 Suppl), p.S114-S118

Mauss, Stefan

2006

Link zum Volltext

Verfügbarkeit prüfen

Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐Registry

Journal of viral hepatitis, 2020-07, Vol.27 (7), p.690-698

2020

Link zum Volltext

Verfügbarkeit prüfen

Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials

Liver international, 2017-02, Vol.37 (2), p.205-211

2017

Link zum Volltext

Verfügbarkeit prüfen

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial

Journal of hepatology, 2020-03, Vol.72 (3), p.431-440

2020

Link zum Volltext

Verfügbarkeit prüfen

Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study

Clinical gastroenterology and hepatology, 2023-03, Vol.21 (3), p.713-722.e3

2023

Link zum Volltext

Verfügbarkeit prüfen

Late presentation of chronic hepatitis C patients in the era of direct‐acting antivirals—Data from the German Hepatitis C‐Registry

Journal of viral hepatitis, 2021-11, Vol.28 (11), p.1660-1664

2021

Link zum Volltext

Verfügbarkeit prüfen

A prospective controlled study of interferon‐based therapy of chronic hepatitis C in patients on methadone maintenance

Hepatology (Baltimore, Md.), 2004-07, Vol.40 (1), p.120-124

2004

Link zum Volltext

Verfügbarkeit prüfen

Obstacles to HBV functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection

Liver international, 2020-12, Vol.40 (12), p.2978-2981

2020

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Digestive diseases and sciences, 2016-10, Vol.61 (10), p.3061-3071

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionTaylor & Francis:Master (3349 titles)

ThemaGastroenterology & Hepatology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(42)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(42)
Science & Technology
(42)
Humans
(29)
Male
(21)
Female
(20)
Hepatitis C
(18)
Middle Aged
(18)
Antiviral Agents - Therapeutic Use
(16)
Adult
(15)
Hepatitis C, Chronic - Drug Therapy
(14)
Hepatitis
(12)
Drug Therapy, Combination
(11)
Germany
(10)
Patients
(10)
Treatment Outcome
(10)
Cirrhosis
(8)
Hepacivirus - Genetics
(8)
Hepatitis C - Drug Therapy
(8)
Infectious Diseases
(8)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Retreatment of patients who failed glecaprevir/pibrentasvir treatment for hepatitis C virus infection

Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection

Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry

Chronic hepatitis C： Treat or wait？ Medical decision making in clinical practice

Renal impairment is frequent in chronic hepatitis C patients under triple therapy with telaprevir or boceprevir

A not so easy genotype—striking regional differences in SOF/RBV treatment responses in HCV GT2

Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients – FINITE study

Prescription of new HCV-drugs - what has to be considered judicially

Real-world effectiveness of 8-week treatment with ledipasvir/sofosbuvir in chronic hepatitis C

The changing characteristics of patients infected with chronic hepatitis C virus from 2014 to 2019: Real‐world data from the German Hepatitis C‐Registry (DHC‐R)

Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry

Baseline risk factors determine lack of biochemical response after SVR in chronic hepatitis C patients treated with DAAs

Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection

Real-world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)

Faldaprevir combined with pegylated interferon alfa‐2a and ribavirin in treatment‐naïve patients with chronic genotype1 HCV: SILEN‐C1 trial

Reply to: “Negotiating better discounts for DAA therapy is critical to achieve HCV elimination by 2030”

Treatment of viral hepatitis in HIV–coinfected patients–adverse events and their management

Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐Registry

Treatment of HCV genotype 2 with sofosbuvir and ribavirin results in lower sustained virological response rates in real life than expected from clinical trials

Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial

Screening HIV Patients at Risk for NAFLD Using MRI-PDFF and Transient Elastography: A European Multicenter Prospective Study

Late presentation of chronic hepatitis C patients in the era of direct‐acting antivirals—Data from the German Hepatitis C‐Registry

A prospective controlled study of interferon‐based therapy of chronic hepatitis C in patients on methadone maintenance

Obstacles to HBV functional cure: Late presentation in HIV and its impact on HBV seroconversion in HIV/HBV coinfection

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

Aktive Filter

Suchergebnisse filtern